Is there a subset of ventilated COVID-19 patients for which tracheotomy may be indicated, whereas considering patient prognosis and the risks of transmission?
The AHA COVID-19 CVD Registry will support greater understanding of the impact of COVID-19 on cardiovascular disease and will inform best practices for evaluation and management of patients with COVID-19.
Although respiratory symptoms are the primary clinical manifestations of COVID-19, a portion of patients will experience severe cardiovascular injury. cTnI is the most important biomarker of cardiac injury.
How to use expertise in a variety of topics to inform and support the prevention, treatment, and caring for people directly and indirectly affected by COVID-19